American Herbal Products Association
Dietary Supplements Regulatory Summit Rescheduled
The 2020 Dietary Supplements Regulatory Summit (DSRS), originally set for May 27, has been rescheduled for Wednesday, Sept. 16, at the same venue, the Mayflower Hotel, in Washington, D.C. All existing registrations and pricing will be honored. New, discounted hotel booking information will be forthcoming shortly. “The five trade associations hosting the summit look forward ...
Food & Beverage Issue Alliance Requests FDA Enforcement Discretion for New Nutrition Labeling Rule
The American Herbal Products Association (AHPA) has joined 12 leading trade associations to advocate FDA (U.S. Food and Drug Administration) to provide flexibility in its enforcement of the new nutrition labeling rules as the January 1, 2020 compliance date approaches. In a letter to Acting FDA Commissioner Dr. Ned Sharpless, the associations, acting as the ...
Colorado Governor Charts Course for CBD and Hemp Innovation
Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month. No stranger to CBD and hemp legislation, Polis called for action for an easier hemp licensing application process, which he ...
AHPA Recommends FDA Implement Policies to Support Responsible Innovation
The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the U.S. Food and Drug Administration (FDA) to support responsible dietary supplement innovation while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products. AHPA submitted these recommendations to FDA in response to an ...
AHPA to Host Inaugural Hemp-CBD Dietary Supplement Congress
The American Herbal Products Association (AHPA) is presenting a two-day Hemp-CBD Supplement Congress in Denver, CO this August to provide critical input for companies navigating the rapidly evolving legal, regulatory and financial landscapes to manufacture and market dietary supplement products with hemp or hemp-derived ingredients including cannabidiol (CBD). The event features presentations from federal officials, ...
FDA Holds CBD Public Hearing
The U.S. Food and Drug Administration (FDA) held a public hearing on cannabidiol, also known as CBD, at its Silver Spring, MD headquarters on Friday, May 31. The New York Times (NYT), called the hearing “the hottest ticket in the capital.” More than 400 applicants, from the U.S. Hemp Roundtable to blue chip law firms, had ...
FDA Announces New Attention to Dietary Supplement Regulations
FDA (U.S. Food and Drug Administration) Commissioner Scott Gottlieb, MD, has announced that the agency is planning “new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA’s oversight,” with a goal of implementing “one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years.” The commissioner’s ...
AHPA Issues Updated Slack-fill Guidance
The American Herbal Products Association (AHPA) has updated its Slack-Fill Guidance to help the regulated supplement industry inform consumers and comply with all relevant federal requirements. This guidance was originally published in November 2016 and has been reorganized and edited for clarity, with one substantive revision in the discussion on “Label statements and fill lines” ...
Nutritional Supplements Access Preserved in Arizona
A proposal that would have drastically limited access to safe, legal and popular products for Arizonans was changed recently with the help of the Natural Products Association (NPA) and the American Herbal Products Association (AHPA), who worked with the Arizona Board of Pharmacy and other state policymakers on the issue. The proposal under consideration would have ...
Trade Associations Warn Consumers of Dangerous Substance Illegally Marketed as a Dietary Supplement
The dietary supplement industry sounded the alarm about the dangers of “phenibut,” a substance being illegally marketed in products fraudulently labeled as dietary supplements. Developed and used as a drug in the former Soviet Union for its supposed brain-enhancing properties, phenibut is not approved as a drug in the United States, nor does it meet ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
